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Volume 49, Number 5S Poster Presentations 37Swhereas the postoperative creatinine level and new onset renal failure requir-
ing hemodialysis differed significantly between the groups (Table).
Conclusions: Endograft implantation in patients with descending
thoracic aneurysm after previous abdominal aortic surgery can be performed
without technical problems. In comparison to patients with conventional
repair, those with endograft implantation have a statistically significantly
lower risk of renal failure and shorter intubation time with less blood
transfusion. Although no statistical difference is present, the early outcome
of endovascular graft treatment appears to be better than that of conven-
tional surgical repair, also in respect to neurological complications and
mortality. Statistical analysis of results in endovascular group and surgical
group.
Variables
Endovascular
group (n29)
Surgical
group
(n20) P value
Age (meanSD) 716.4 696.4 n.s.
Sex(male/female) 24/5 16/4 n.s.
Creatinine (mg/dl) 1.571.4 1.420.5 n.s.
Preop.(meanSD)Postop.
(meanSD)
1.921.7 2.31.2 0.04
Postop. dialyses (n) 1 (3.4%) 6 (30%) 0.02
Neurological complications (n) 2 (6.8%) 3 (15%) n.s.
Intubation time (hours)
(median) (range)
6 (3-720) 60 (24-1560) 0.001
Blood transfusion (ml)
(meanSD)
(249456) (21261809) 0.01
Secondary thoracotomy (n) 1 (3.4%) 3 (15%) n.s.
30-day mortality (n) 2 (6.8%) 3 (15%) n.s.
Author Disclosures: S. Buz,None;B. Zipfel,None;B. Tutkun,None;R.
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Objective: Controlled hypotension is critical for precise deployment of
endografts in the thoracic aorta and for safe balloon dilation after deploy-
ment. Rapid right ventricular pacing (RRVP) via a transfemoral venous
catheter has been reported previously as a technique to facilitate thoracic
endograft placement. We describe a novel approach to RRVP using a
pulmonary artery catheter (PAC) that is placed during the endograft proce-
dure for hemodynamic monitoring.
Methods:Clinical and radiological records of 12 patients (8 men and 4
women, mean age 80 years, range 75 - 89) who underwent endograft
placement in the thoracic aorta with PAC- directed RRVP were reviewed.
Endografts were placed to treat thoracic aneurysms (mean size 65 8 mm)
in 10 patients, and penetrating aortic ulcers in 2 patients. All endografts but
one were deployed in the proximal aorta (zones 1-3). Hemodynamic param-
eters, accuracy of deployment, complications related to RRVP and PAC
placement, presence of endoleaks and postoperative complications were
evaluated.
Results: PAC-directed RRVPwas performed during endograft deploy-
ment and post-deployment balloon dilation without technical difficulty or
delayed recovery in all patients. A median of two pacing episodes were
performed for each patient (range 1-4). The length of each pacing episode
was less than 15 seconds (mean 11 seconds, range 6-14). Mean pacing rate
was 165  15 beats per minute which achieved an average mean arterial
pressure of 42 8 mm Hg for a mean duration of 16 seconds. After pacing
cessation, the recovery time of mean arterial pressure from 428 mmHg to
pre-pacing levels was within 8 seconds in all patients. All endografts were
deployed with precise positioning at amean of 2.52mm from the intended
placement site. No complications related to RRVP or PAC placement
occurred. No type I endoleaks nor postoperative complications were ob-
served. There was no peri-operative mortality.
Conclusion: PAC-directed RRVP is a safe and effective method of
inducing hypotension, enabling precise thoracic endograft deployment and
safe balloon dilation after deployment. It avoids the use of femoral venous
access and its associated potential complications, and obviates the need to
involve a cardiologist, simplifying the procedure and utilizing resources
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Repair of Thoracoabdominal Aneurysms: Improvement with Adjuncts
but Still High Risk
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Peter Taylor. Guy’s & St Thomas’ NHS Foundation Trust, London, United
Kingdom
Objective: Open repair of descending thoracoabdominal aneurysms
(TAA) is associated with significant mortality and morbidity. We assessed the
impact of surgical adjuncts on outcomes for patients undergoing open TAA
repair.
Methods: Retrospective analysis of a prospectively maintained data-
base was performed to assess the impact of adjunctive techniques on out-
comes for patients undergoing elective TAA repair (Crawford type I-IV)
between January 1992 and January 2008. Patients were divided into two
groups based on the period of operation: group A (1992-2000) and group
B (2000-2008). Surgical adjuncts were introduced for patients in group B
(CSF drainage for all; distal aortic perfusion and selective visceral perfusion
for type I, II and III aneurysms only; a cell saver for type IV).
Results: A consecutive series of 109 patients with a median age of 69
years (range 21-89) were analysed. The mean operating time for group A
(n31) was 195 minutes (range 140-480) compared with 200 minutes
(range 90-300) in group B (n78). Median blood loss for group A was
3682 ml (range 2495-10000) compared with 3000 ml (range 400-17000)
for group B. The combined mortality rate was 32.2% in group A (type I-III,
25.0%; type IV, 37.4%) compared with 14.1% in group B (type I-III, 17.1%;
type IV, 10.8%;p0.03).The overall complication rate in group Awas 61.3%
(type I-III, 50.0%; type IV, 68.8%) compared with 37.1% in group B (type
I-III, 48.8%; type IV, 21.6%; p0.02). The overall paraplegia rate was 12.9%
in group A (type I-III, 18.8%; type IV, 6.3%) compared with 7.7% in group
B type I-III, 14.6%; type IV, 0%).
Conclusions: Series from individual specialist centres report excellent
outcomes after TAA repair but this is in contrast with multi-centre data. The
introduction of adjunctive techniques in our series has resulted in a reduc-
tion inmortality and complication rates but they remain high.Monitoring of
spinal cord function may reduce the rate of paraplegia.
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Objective: To discuss the causation and prevention of the stent-graft-
induced new entry (SINE) following endovascular aortic repair (EVAR) for
type B dissection.
Methods: SINE was defined as the new tear caused by the stent-graft
itself, excluding those created by the injury from any inappropriate endovas-
cular manipulation. Twenty one paitents with SINE were retrospectively
collected and analysed out of 650 cases undergoing EVAR for type B
dissection from August 2000 to June 2008 in our center.
Results: Totally, there were 22 SINEs found in 21cases. SINE oc-
curred at the proximal end of the endograft in 15 cases, at the distal in 5, and
at both in 1. Its incidence was 3.2% and onset time varied from post-
operative 2 hours to 60 months (mean 915 months). All 16 proximal
SINEs lead to retrograde type A dissection. Two distal SINEs caused
enlarging aneurysm and 4 remained stable. Devices used and management
are shown in the Table. Devices Used and Management of SINEs SINE
indicates the stent-graft-induced new entry. Six patients died and the mor-
tality reached 29%. All 21 cases had the endograft placed across the distal
aortic arch. Thirteen proximal SINEs were evidenced at the greater curve of
the arch, and all distal SINEs at the dissection flap.
